KMT2A and acute myeloid leukemia: In the MLL‐NRIP3‐AML model, a combination of cold exposure with the standard chemotherapy produced a significant enhancement of the anti‐leukemic effect (Figure 5B–D; Figure S5A,B, Supporting Information).